The first drug specifically approved for the treatment of pulmonary hypertension is Epoprostenol (Flolan).
Epoprostenol (Flolan) for Pulmonary Hypertension
Epoprostenol, often known by its brand name Flolan, holds a significant place in the history of pulmonary hypertension treatment.
Key Aspects:
- First Approved Treatment: Epoprostenol was the first medication specifically designed and approved to treat pulmonary hypertension. This marked a turning point in managing this condition.
- Treatment for Advanced Disease: The reference states, "Flolan is the most effective drug for the treatment of advanced disease," highlighting its potency and suitability for individuals with severe pulmonary hypertension.
Therefore, when considering the initial or pioneering treatment option, Epoprostenol (Flolan) stands out as the primary answer.
